You are here

Gardasil

Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits

Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits

BioSpace

Flag link:

Court Orders Merck to Produce Entire Database of Gardasil Adverse Events

Court Orders Merck to Produce Entire Database of Gardasil Adverse Events

EIN Newswires

Flag link:

Merck, nearing completion of $1B Gardasil manufacturing push, eyes 2023 to double production⁠—again

Merck, nearing completion of $1B Gardasil manufacturing push, eyes 2023 to double production⁠—again

Fierce Pharma

drug manufacturing

Flag link:

Merck looks ahead to a COVID-19 drug and vaccine—and a Gardasil recovery—as pandemic takes a $2.5B toll

Merck looks ahead to a COVID-19 drug and vaccine—and a Gardasil recovery—as pandemic takes a $2.5B toll

Fierce Pharma

Flag link:

National Vaccination Program Leads To Marked Reduction In HPV Infections

National Vaccination Program Leads To Marked Reduction In HPV Infections

Forbes

Flag link:

Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openings

Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openings

Fierce Pharma

drug manufacturing

Flag link:

Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China

Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China

Fierce Pharma

Flag link:

Merck again borrows Gardasil supplies from CDC

Merck again borrows Gardasil supplies from CDC

Biopharma Dive

Flag link:

New evidence shows why the HPV vaccine is as important for boys as girls

New evidence shows why the HPV vaccine is as important for boys as girls

Stat

Flag link:

Merck's spending big to support Gardasil, and the HPV vaccine keeps pumping along

Merck's spending big to support Gardasil, and the HPV vaccine keeps pumping along

Fierce Pharma

Flag link:

Just One HPV Dose May Be Enough To Prevent Several Cancers

Just One HPV Dose May Be Enough To Prevent Several Cancers

Forbes

cervical cancer

Flag link:

Merck Keeps Expansions Rolling with New N.C. Manufacturing Site

Merck Keeps Expansions Rolling with New N.C. Manufacturing Site

BioSpace

drug manufacturing

Flag link:

Updated HPV Vaccine Recommendations Follow Big HPV Infection Drops Shown In New Study

Updated HPV Vaccine Recommendations Follow Big HPV Infection Drops Shown In New Study

Forbes

Flag link:

U.S. advisory panel stops short of broad recommendations for two common vaccines

U.S. advisory panel stops short of broad recommendations for two common vaccines

Stat

advisory panels

Flag link:

Merck's Gardasil blockbuster sales prompt $1B plant expansion

Merck's Gardasil blockbuster sales prompt $1B plant expansion

Fierce Pharma

drug manufacturing

Flag link:

Keytruda drives another strong Merck quarter, but what’s next?

Keytruda drives another strong Merck quarter, but what’s next?

Pharmaforum

Flag link:

Merck increased list prices on Keytruda, Gardasil in November

Merck increased list prices on Keytruda, Gardasil in November

Biopharma Dive

Flag link:

'Unprecedented' demand for Merck's Gardasil drives monster Q3

'Unprecedented' demand for Merck's Gardasil drives monster Q3

Fierce Pharma

Flag link:

HPV-related cancer rises, despite higher vaccination rates

HPV-related cancer rises, despite higher vaccination rates

Bizjournals.com

cervical cancer

Flag link:

No Ovarian Failure Risk After HPV Vaccine, Study Finds

No Ovarian Failure Risk After HPV Vaccine, Study Finds

Forbes

primary ovarian insufficiency

Flag link:

Pages